IL2RG and familial pancreatic carcinoma: In 2017, Ayars and al, using CRISPR-mediated knockout of IL2RG in orthotopically implanted pancreatic cancer cells, observed a reduction in tumor growth in mice and decreased JAK3 in orthotopic tumors.